Progress
Quantity
74746
Category
Bupivacaine 5 percent Inj
Bid Type
Two Packet Bid
Indian Army has released a public tender for Bupivacaine 5 percent Inj, Indomethacin 25 mg Cap, Cyproheptadine 4mg, Carbamazepine 200 mg, Lamotrigine 25 mg, Nifedipine 30 mg, Sofosbuvir 400 mg plus Ledipasvir 90 mg, Inj Etomidate 2 mg per ml 10 ml Vial, Midazolam 5 mg 1 ml Inj, Paracetamol Suppository 80 mg, Aspirin Soluble 325mg, Paracetamol Infusion Inj, Betamethasone Cream 0 point 1 percent, Folic Acid, Ivermectin 6mg in AMRITSAR, PUNJAB. Quantity: 74746. Submission Deadline: 23-04-2025 14: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Bupivacaine 5 percent Inj , Indomethacin 25 mg Cap , Cyproheptadine 4mg , Carbamazepine 200 mg , Lamotrigine 25 mg , Nifedipine 30 mg , Sofosbuvir 400 mg plus Ledipasvir 90 mg , Inj Etomidate 2 mg per ml 10 ml Vial , Midazolam 5 mg 1 ml Inj , Paracetamol Suppository 80 mg , Aspirin Soluble 325mg , Paracetamol Infusion Inj , Betamethasone Cream 0 point 1 percent , Folic Acid , Ivermectin 6mg
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Bupivacaine 5 percent Inj
As Per Specifications (Pdf Attached)
Indomethacin 25 mg Cap
As Per Specifications (Pdf Attached)
Cyproheptadine 4mg
As Per Specifications (Pdf Attached)
Carbamazepine 200 mg
As Per Specifications (Pdf Attached)
Lamotrigine 25 mg
As Per Specifications (Pdf Attached)
Nifedipine 30 mg
As Per Specifications (Pdf Attached)
Sofosbuvir 400 mg plus Ledipasvir 90 mg
As Per Specifications (Pdf Attached)
Inj Etomidate 2 mg per ml 10 ml Vial
As Per Specifications (Pdf Attached)
Midazolam 5 mg 1 ml Inj
As Per Specifications (Pdf Attached)
Paracetamol Suppository 80 mg
As Per Specifications (Pdf Attached)
Aspirin Soluble 325mg
As Per Specifications (Pdf Attached)
Paracetamol Infusion Inj
As Per Specifications (Pdf Attached)
Betamethasone Cream 0 point 1 percent
As Per Specifications (Pdf Attached)
Folic Acid
As Per Specifications (Pdf Attached)
Ivermectin 6mg
As Per Specifications (Pdf Attached)
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Bupivacaine 5 percent Inj | As Per Specifications (Pdf Attached) | 180 | no | [email protected] | 15 | |
| 2 | Indomethacin 25 mg Cap | As Per Specifications (Pdf Attached) | 840 | no | [email protected] | 15 | |
| 3 | Cyproheptadine 4mg | As Per Specifications (Pdf Attached) | 1,575 | no | [email protected] | 15 | |
| 4 | Carbamazepine 200 mg | As Per Specifications (Pdf Attached) | 1,680 | no | [email protected] | 15 | |
| 5 | Lamotrigine 25 mg | As Per Specifications (Pdf Attached) | 90 | no | [email protected] | 15 | |
| 6 | Nifedipine 30 mg | As Per Specifications (Pdf Attached) | 600 | no | [email protected] | 15 | |
| 7 | Sofosbuvir 400 mg plus Ledipasvir 90 mg | As Per Specifications (Pdf Attached) | 400 | no | [email protected] | 15 | |
| 8 | Inj Etomidate 2 mg per ml 10 ml Vial | As Per Specifications (Pdf Attached) | 30 | vial | [email protected] | 15 | |
| 9 | Midazolam 5 mg 1 ml Inj | As Per Specifications (Pdf Attached) | 756 | amp vial | [email protected] | 15 | |
| 10 | Paracetamol Suppository 80 mg | As Per Specifications (Pdf Attached) | 330 | no | [email protected] | 15 | |
| 11 | Aspirin Soluble 325mg | As Per Specifications (Pdf Attached) | 150 | no | [email protected] | 15 | |
| 12 | Paracetamol Infusion Inj | As Per Specifications (Pdf Attached) | 4,560 | bott | [email protected] | 15 | |
| 13 | Betamethasone Cream 0 point 1 percent | As Per Specifications (Pdf Attached) | 15 | no | [email protected] | 15 | |
| 14 | Folic Acid | As Per Specifications (Pdf Attached) | 63,300 | no | [email protected] | 15 | |
| 15 | Ivermectin 6mg | As Per Specifications (Pdf Attached) | 240 | no | [email protected] | 15 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ARORA BROS MEDILINKERS Under PMA | - | 22-04-2025 16:47:31 | |
| 2 | CHOWDHARY PHARMACEUTICALS Under PMA | - | 23-04-2025 11:23:38 | |
| 3 | DIVIT NUTRACEUTICALS PRIVATE LIMITED Under PMA | - | 22-04-2025 11:11:26 | |
| 4 | GOYAL MEDICAL & GENERAL AGENCY Under PMA | - | 21-04-2025 16:45:20 | |
| 5 | LAKSHMI ENTERPRISES Under PMA | - | 23-04-2025 11:35:03 | |
| 6 | M/S J.R.BIOTECH Under PMA | - | 22-04-2025 21:09:50 | |
| 7 | M/S NEW WAVES Under PMA | - | 22-04-2025 18:25:32 | |
| 8 | MAMMOTH LIFESCIENCES LLP Under PMA | - | 23-04-2025 12:34:00 | |
| 9 | MASKON LIFE SCIENCES PRIVATE LIMITED Under PMA | - | 03-04-2025 10:12:24 | |
| 10 | MEDICAL EQUIPMENT AND ENGG COMPANY Under PMA | - | 20-04-2025 15:31:56 | |
| 11 | MODERN MEDICAL HALL Under PMA | - | 23-04-2025 13:10:52 | |
| 12 | NEEL KANTH MEDICAL STORE Under PMA | - | 23-04-2025 13:14:57 | |
| 13 | NUTRAKEM INDIA PRIVATE LIMITED Under PMA | - | 04-04-2025 17:30:52 | |
| 14 | R.P.S.PHARMA Under PMA | - | 22-04-2025 14:16:24 | |
| 15 | RADIANT PHARMACHEM Under PMA | - | 23-04-2025 12:26:53 | |
| 16 | RADKRISH HEALTHCARE INC Under PMA | - | 16-04-2025 16:55:07 | |
| 17 | REKIN PHARMA PRIVATE LIMITED Under PMA | - | 23-04-2025 10:17:40 | |
| 18 | SAI KIRPA SURGICALS Under PMA | - | 23-04-2025 13:36:52 | |
| 19 | SANJIVNI AGENCIES Under PMA | - | 23-04-2025 12:25:16 | |
| 20 | SINGLA MEDICARE Under PMA | - | 23-04-2025 10:09:55 | |
| 21 | sk life sciences Under PMA | - | 22-04-2025 19:39:20 | |
| 22 | SMPL LIFE SCIENCES PRIVATE LIMITED Under PMA | - | 23-04-2025 12:01:11 | |
| 23 | SONDHI SONS PHARMA Under PMA | - | 22-04-2025 16:30:34 | |
| 24 | SRI SAI AGENCIES Under PMA | - | 15-04-2025 11:06:18 | |
| 25 | SUNIL PHARMACY Under PMA | - | 23-04-2025 11:38:24 | |
| 26 | WELNEX BIO PRIVATE LIMITED Under PMA | - | 10-04-2025 13:26:12 |
Key insights about PUNJAB tender market
The eligibility requirements include being a registered entity in the pharmaceutical sector, having valid licenses, and possessing prior experience in supplying medical products. Additionally, compliance with quality and safety standards set forth by relevant authorities is crucial.
Bidders must submit essential certificates such as a Certificate of Analysis for each product, batch test reports, and documentation verifying adherence to Good Manufacturing Practices (GMP). These certifications ensure that products meet the established health and safety standards.
The registration process involves creating an account on the designated e-procurement platform outlined in the tender. Participants will need to provide essential documents, including registration details and requisite financial statements, to complete their registration.
Bidders are required to submit performance security, equivalent to a certain percentage of the contract value, to ensure compliance with the terms of the contract. This is a safeguard to cover potential damages due to non-fulfilment of tender obligations.
The tender incorporates benefits for MSEs, such as preferential evaluation criteria aimed at providing easier access for smaller businesses to participate. Relaxed eligibility conditions also promote growth and participation from startups and emerging companies within the pharmaceutical sector.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS